Home › Companies › Fulcrum Therapeutics, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Fulcrum Therapeutics, Inc.’s Form 8-K, filed June 25, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 24, 2026: 5 items on Fulcrum Therapeutics, Inc.’s Form 8-K, filed June 25, 2026: 2 approved · 3 passed (calculated).
Notable dissent: 1 director (19.7% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2024-2025 2025-2026
Activist investors: Tang Capital (13F, 9.3%, as of September 30, 2026) · Nantahala Capital (13F, 8.6%, as of September 30, 2026)
Explore Fulcrum Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Fulcrum Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sonja Banks | 43,187,717 | -- | -- | 10,601,385 | 5,062,117 | 80% | Passed (calculated) | — |
| Elect Director: Alan Ezekowitz | 52,317,282 | -- | -- | 1,471,820 | 5,062,117 | 97% | Passed (calculated) | — |
| Elect Director: Colin Hill | 52,363,595 | -- | -- | 1,425,507 | 5,062,117 | 97% | Passed (calculated) | — |
| Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers. | 50,735,617 | 3,026,397 | 27,088 | -- | 5,062,117 | 94% | Approved | — |
| Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. | 58,793,645 | 36,178 | 21,396 | -- | 0 | 99.9% | Approved | — |
Source: Fulcrum Therapeutics, Inc., Form 8-K, filed with the SEC on June 25, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
169 asset managers disclosed a vote on at least one Fulcrum Therapeutics, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz
Fulcrum Therapeutics, Inc.’s own tally for this item (“Elect Director: Alan Ezekowitz”): 52,317,282 for, 1,471,820 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 9,169,393 for, 329,047 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,243,199 | 0 | 3 | 4,611 | For |
| BlackRock | 2,827,014 | 0 | 0 | 0 | For |
| Fidelity | 1,253,326 | 0 | 0 | 0 | For |
| Charles Schwab | 426,963 | 0 | 0 | 0 | For |
| State Street | 343,783 | 0 | 0 | 106 | For |
| Dimensional | 0 | 0 | 0 | 252,690 | Withhold |
| American Century | 156,242 | 0 | 0 | 0 | For |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 116,834 | 0 | 0 | 0 | For |
| Equitable | 94,568 | 0 | 0 | 18,660 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 85,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,194 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,548 | 0 | 0 | 10,042 | Mixed |
| Northern Trust | 43,896 | 0 | 0 | 0 | For |
| Russell Investments | 33,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 29,462 | 0 | 0 | 0 | For |
| Global X | 25,920 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,481 | 0 | 0 | 0 | For |
| ProShares | 25,456 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 24,078 | 0 | 0 | 0 | For |
| Pacific Life | 22,550 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 20,361 | 0 | 0 | 0 | For |
| Brighthouse | 19,248 | 0 | 0 | 0 | For |
| John Hancock | 14,642 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 14,631 | Withhold |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill
Fulcrum Therapeutics, Inc.’s own tally for this item (“Elect Director: Colin Hill”): 52,363,595 for, 1,425,507 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 9,174,462 for, 323,977 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,247,809 | 0 | 3 | 0 | For |
| BlackRock | 2,827,014 | 0 | 0 | 0 | For |
| Fidelity | 1,253,326 | 0 | 0 | 0 | For |
| Charles Schwab | 426,963 | 0 | 0 | 0 | For |
| State Street | 343,889 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 252,690 | Withhold |
| American Century | 156,242 | 0 | 0 | 0 | For |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 116,834 | 0 | 0 | 0 | For |
| Equitable | 94,568 | 0 | 0 | 18,660 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 85,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,194 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,548 | 0 | 0 | 10,042 | Mixed |
| Northern Trust | 43,896 | 0 | 0 | 0 | For |
| Russell Investments | 33,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 29,462 | 0 | 0 | 0 | For |
| Global X | 25,920 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,481 | 0 | 0 | 0 | For |
| ProShares | 25,456 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 24,078 | 0 | 0 | 0 | For |
| Pacific Life | 22,550 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 20,361 | 0 | 0 | 0 | For |
| Brighthouse | 19,248 | 0 | 0 | 0 | For |
| John Hancock | 14,642 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 14,631 | Withhold |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks
Fulcrum Therapeutics, Inc.’s own tally for this item (“Elect Director: Sonja Banks”): 43,187,717 for, 10,601,385 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,728,837 for, 769,589 withheld, 17 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,209,493 | 0 | 17 | 38,302 | For |
| BlackRock | 2,827,014 | 0 | 0 | 0 | For |
| Fidelity | 1,236,032 | 0 | 0 | 17,294 | For |
| Charles Schwab | 426,963 | 0 | 0 | 0 | For |
| State Street | 343,622 | 0 | 0 | 267 | For |
| Dimensional | 0 | 0 | 0 | 252,690 | Withhold |
| American Century | 0 | 0 | 0 | 156,242 | Withhold |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 116,834 | 0 | 0 | 0 | For |
| Equitable | 94,568 | 0 | 0 | 18,660 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 85,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,194 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,900 | 0 | 0 | 34,690 | Mixed |
| Northern Trust | 0 | 0 | 0 | 43,896 | Withhold |
| Russell Investments | 33,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 29,462 | Withhold |
| Global X | 25,920 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,481 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 25,456 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 24,078 | 0 | 0 | 0 | For |
| Pacific Life | 22,550 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 20,361 | Withhold |
| Brighthouse | 0 | 0 | 0 | 19,248 | Withhold |
| John Hancock | 0 | 0 | 0 | 14,642 | Withhold |
| Jackson National | 0 | 0 | 0 | 14,631 | Withhold |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
94% Approved · of votes cast
Prior year: 99.8% for (June 26, 2025 meeting) ▼ 5.4 pts
Description as filed by funds: A non-binding advisory vote to approve the compensation of our named executive officers;
Fulcrum Therapeutics, Inc.’s own tally for this item (“Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”): 50,735,617 for, 3,026,397 against — passed, per its Form 8-K filed June 25, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “b) Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Fulcrum Therapeutics, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “SAY ON PAY” (2 managers, no shares for or against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,247,810 | 1 | 0 | 0 | For |
| BlackRock | 2,827,014 | 0 | 0 | 0 | For |
| Fidelity | 1,253,326 | 0 | 0 | 0 | For |
| Charles Schwab | 426,963 | 0 | 0 | 0 | For |
| State Street | 343,824 | 65 | 0 | 0 | For |
| Dimensional | 252,690 | 0 | 0 | 0 | For |
| American Century | 0 | 156,242 | 0 | 0 | Against |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 116,834 | 0 | 0 | 0 | For |
| Equitable | 113,228 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 85,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,194 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,590 | 0 | 0 | 0 | For |
| Northern Trust | 43,896 | 0 | 0 | 0 | For |
| Russell Investments | 33,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 29,462 | 0 | 0 | 0 | For |
| Global X | 25,920 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,481 | 0 | 0 | 0 | For |
| ProShares | 25,456 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 24,078 | 0 | 0 | 0 | For |
| Pacific Life | 22,550 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 20,361 | 0 | 0 | 0 | For |
| Brighthouse | 19,248 | 0 | 0 | 0 | For |
| John Hancock | 14,642 | 0 | 0 | 0 | For |
| Jackson National | 14,631 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 9,327,803 for, 156,309 against, 14,329 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 6,463,818 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 6,053,960 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 2,430,153 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,400,000 | 0 | 0 | 0 | For |
| BlackRock | 2,237,156 | 22,647 | 0 | 0 | For |
| Aberdeen | 0 | 2,211,953 | 0 | 0 | Against |
| State Street | 1,371,855 | 4,039 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,367,792 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,002,718 | 0 | 0 | 0 | For |
| Point72 | 996,763 | 0 | 0 | 0 | For |
| Citadel | 778,602 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 728,620 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 725,246 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 598,870 | 0 | 0 | 0 | For |
| DE Shaw | 597,099 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 453,914 | 0 | 0 | Against |
| Charles Schwab | 426,977 | 0 | 0 | 0 | For |
| AQR | 424,663 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 396,499 | 2,386 | 0 | 0 | For |
| Vanguard | 359,128 | 0 | 0 | 0 | For |
| Northern Trust | 329,977 | 2,813 | 0 | 0 | For |
| Bessemer Trust CO of Delaware, N.A. | 292,760 | 0 | 0 | 0 | For |
| BESSEMER TRUST CO | 289,237 | 0 | 0 | 0 | For |
| BESSEMER TRUST Co OF FLORIDA | 289,237 | 0 | 0 | 0 | For |
| Bessemer Trust Co of California, N.A. | 289,237 | 0 | 0 | 0 | For |
Institutional-manager reports, all 132 managers: 33,960,399 for, 2,909,445 against, 10,158 abstained, 460 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and
Fulcrum Therapeutics, Inc.’s own tally for this item (“Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 58,793,645 for, 36,178 against — passed, per its Form 8-K filed June 25, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “d) Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 9,484,059 for, 55 against, 14,329 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,247,812 | 0 | 0 | 0 | For |
| BlackRock | 2,827,014 | 0 | 0 | 0 | For |
| Fidelity | 1,253,326 | 0 | 0 | 0 | For |
| Charles Schwab | 426,963 | 0 | 0 | 0 | For |
| State Street | 343,834 | 55 | 0 | 0 | For |
| Dimensional | 252,690 | 0 | 0 | 0 | For |
| American Century | 156,242 | 0 | 0 | 0 | For |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 116,834 | 0 | 0 | 0 | For |
| Equitable | 113,228 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 85,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,194 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,590 | 0 | 0 | 0 | For |
| Northern Trust | 43,896 | 0 | 0 | 0 | For |
| Russell Investments | 33,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 29,462 | 0 | 0 | 0 | For |
| Global X | 25,920 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,481 | 0 | 0 | 0 | For |
| ProShares | 25,456 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 24,078 | 0 | 0 | 0 | For |
| Pacific Life | 22,550 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 20,361 | 0 | 0 | 0 | For |
| Brighthouse | 19,248 | 0 | 0 | 0 | For |
| John Hancock | 14,642 | 0 | 0 | 0 | For |
| Jackson National | 14,631 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 66,633,321 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.87% |
| 2 | BlackRock | 4.24% |
| 3 | Fidelity | 1.88% |
| 4 | Charles Schwab | 0.64% |
| 5 | State Street | 0.52% |
| 6 | Dimensional | 0.38% |
| 7 | American Century | 0.23% |
| 8 | TIAA | 0.19% |
| 9 | Simplify Exchange Traded Funds | 0.18% |
| 10 | Equitable | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 9.70% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 9.09% |
| 3 | Nantahala Capital Management, LLC | 3.65% |
| 4 | Siren, L.L.C. | 3.60% |
| 5 | BlackRock | 3.39% |
| 6 | Aberdeen | 3.32% |
| 7 | State Street | 2.06% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.05% |
| 9 | BRAIDWELL LP | 1.50% |
| 10 | Point72 | 1.50% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| RA Capital Management, L.P. | 6,649,973 | 9.98% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| Suvretta Capital Management, LLC | 6,178,505 | 9.27% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| Nantahala Capital Management, LLC | 5,677,912 | 8.52% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| BlackRock | 5,390,593 | 8.09% | Form 13F, quarter ended March 31, 2026 |
| TCG Crossover GP II, LLC | 5,000,000 | 7.50% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 4,468,123 | 6.71% | Schedule 13G, filed August 3, 2026 |
| Montanova Capital, LLC | 3,680,921 | 5.52% | Schedule 13G, filed August 14, 2026 |
| Vanguard Group | 3,559,552 | 5.34% | Form 13F, quarter ended March 31, 2026 |
| Alex C. Sapir | 2,096,219 | 3.15% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| Point72 | 2,074,855 | 3.11% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 66,633,321 shares outstanding, as reported by Fulcrum Therapeutics, Inc. on its Form 10-Q dated April 20, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Fulcrum Therapeutics, Inc.'s shareholder meeting held June 24, 2026, in the 2025-2026 proxy season, 169 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 951 separate fund positions. On the most widely held item on that ballot — A non-binding advisory vote to approve the compensation of our named executive officers; — Fulcrum Therapeutics, Inc.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Fulcrum Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Fulcrum Therapeutics, Inc.’s 10-Q dated April 20, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Fulcrum Therapeutics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Fulcrum Therapeutics (FULC) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/fulcrum-therapeutics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.